Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (250 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 19 Aug 2024 – 20 Aug 2026, limited by Invesco India Manufacturing Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Invesco India Manufacturing Fund | Nifty 500 |
|---|---|---|
| 19 Aug 2024 | ₹100.00 | ₹100.00 |
| 19 Oct 2024 | ₹104.97 | ₹101.30 |
| 19 Dec 2024 | ₹106.16 | ₹98.32 |
| 18 Feb 2025 | ₹87.29 | ₹89.07 |
| 20 Apr 2025 | ₹93.55 | ₹93.70 |
| 20 Jun 2025 | ₹100.30 | ₹99.57 |
| 20 Aug 2025 | ₹103.57 | ₹100.01 |
| 19 Oct 2025 | ₹104.47 | ₹101.98 |
| 19 Dec 2025 | ₹100.00 | ₹102.32 |
| 18 Feb 2026 | ₹103.28 | ₹102.19 |
| 20 Apr 2026 | ₹104.47 | ₹98.82 |
| 20 Jun 2026 | ₹112.91 | ₹100.02 |
| 20 Aug 2026 | ₹123.04 | ₹101.61 |
| Metric | Invesco · Direct · IDCW NAV ₹12.39 Very High risk ★★★★☆ 1Y | Category median Sectoral/ Thematic · 250 funds |
|---|---|---|
| +18.79% | +5.11% | |
| — | +13.02% | |
| — | +11.14% | |
| — | +12.26% | |
| +10.91% | +11.82% | |
| +19.73% | — | |
| — | +14.62% | |
| — | +12.95% | |
| — | +13.24% | |
| Risk | ||
| 17.09% | 15.88% | |
| 0.72 | 0.35 | |
| 0.98 | 0.47 | |
| -21.64% | -25.18% | |
| Nifty 500 | — | |
| — | +1.40% | |
| — | 0.98 | |
| — | 101.5% | |
| — | 97.0% | |
| 1.10% | 1.14% | |
| ₹663.48Cr | ₹1,162Cr | |
| 0.50% | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 59% | 45% | |
| Nikhil Kale · 0.7y | — | |
| 19 Aug 2024 | — | |
| 50 | — | |
| 35.2% | — | |
| 0.8% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.